{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T06:17:51Z","timestamp":1794205071692,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Describe the efficacy of a galenic glycopyrrolate formulation and its impact on patients with sialorrhea Quality of Life (QoL), including costs analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a retrospective observational study on 21 patients who received a custom-formulated galenic glycopyrrolate syrup for sialorrhea for an average period of 14.3\u2009months. We analyzed the telephone interviews with elaborated and validated questionnaires and the therapy costs comparing the brand marketed drug with the galenic formulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 16 out of 21 patients (76.2%) reported a significant improvement in sialorrhea and QoL. In 14 subjects (66.7%), there was a remarkable decrease in the drooling severity; 10 individuals (47.6%) reported a reduction in drooling frequency. Nine patients experienced at least one adverse effect of glycopyrrolate therapy, and three of them stopped the treatment. No severe side effects were observed. The galenic drug significantly reduced costs for patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>An oral glycopyrrolate solution easily administered to children with brain injuries is not commercially available in many European countries. This study demonstrates the efficacy of a compounded glycopyrrolate syrup on drooling severity, frequency and ensures a better QoL in patients and their caregivers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-021-01173-7","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T20:02:32Z","timestamp":1636228952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience"],"prefix":"10.1186","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1350-0509","authenticated-orcid":false,"given":"Davide","family":"Zanon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tumminelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria Chiara","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Torelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Maestro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidio","family":"Barbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Maximova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,6]]},"reference":[{"issue":"1","key":"1173_CR1","first-page":"E22","volume":"13","author":"MC Morales Ch\u00e1vez","year":"2008","unstructured":"Morales Ch\u00e1vez MC, Nualart Grollmus ZC, Silvestre-Donat FJ. Clinical prevalence of drooling in infant cerebral palsy. Med Oral Patol Oral Cir Bucal. 2008;13(1):E22\u20136.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"11","key":"1173_CR2","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1469-8749.2012.04412.x","volume":"54","author":"P Blasco","year":"2012","unstructured":"Blasco P. Prevalence and predictors of drooling. Dev Med Child Neurol. 2012;54(11):970. https:\/\/doi.org\/10.1111\/j.1469-8749.2012.04412.x.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"1173_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1745-6215-15-60","volume":"15","author":"JR Parr","year":"2014","unstructured":"Parr JR, Weldon E, Pennington L, Steen N, Williams J, Fairhurst C, et al. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability. Trials. 2014;15(1):60. https:\/\/doi.org\/10.1186\/1745-6215-15-60.","journal-title":"Trials."},{"key":"1173_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2147\/NDT.S39253","volume":"8","author":"SC Chang","year":"2012","unstructured":"Chang SC, Lin CK, Tung LC, et al. The association of drooling and health-related QoL in children with cerebral palsy. Neuropsychiatr Dis Treat. 2012;8:599\u2013604.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"1173_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/MOO.0b013e328011014a","volume":"14","author":"D Lal","year":"2006","unstructured":"Lal D, Hotaling AJ. Drooling. Curr Opin Otolaryngol Head Neck Surg. 2006;14(6):381\u20136. https:\/\/doi.org\/10.1097\/MOO.0b013e328011014a.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"1173_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/dmcn.14048","volume":"61","author":"MS McInerney","year":"2019","unstructured":"McInerney MS, Reddihough DS, et al. Behavioural interventions to treat drooling in children with neurodisability: a systematic review. Dev Med Child Neurol. 2019;61:39\u201348.","journal-title":"Dev Med Child Neurol"},{"key":"1173_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jocn.2018.02.011","volume":"51","author":"K Sridharan","year":"2018","unstructured":"Sridharan K, Sivaramakrishnan G. Pharmacological interventions for treating sialorrhea associated with neurological disorders: a mixed treatment network meta-analysis of randomized controlled trials. J Clin Neurosci. 2018;51:12\u20137. https:\/\/doi.org\/10.1016\/j.jocn.2018.02.011.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"1173_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ejpn.2016.04.010","volume":"20","author":"E Chal\u00e9at-Valayer","year":"2016","unstructured":"Chal\u00e9at-Valayer E, Porte M, Buchet-Poyau K, Roumenoff-Turcant F, D'Anjou MC, Boulay C, et al. Management of drooling in children with cerebral palsy: a French survey. Eur J Paediatr Neurol. 2016;20(4):524\u201331. https:\/\/doi.org\/10.1016\/j.ejpn.2016.04.010.","journal-title":"Eur J Paediatr Neurol"},{"key":"1173_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.taap.2019.03.016","volume":"370","author":"M Chabicovsky","year":"2019","unstructured":"Chabicovsky M, Winkler S, Soeberdt M, Kilic A, Masur C, Abels C. Pharmacology, toxicology and clinical safety of glycopyrrolate. Toxicol Appl Pharmacol. 2019;370:154\u201369. https:\/\/doi.org\/10.1016\/j.taap.2019.03.016.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"1173_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2165\/11208120-000000000-00000","volume":"14","author":"KP Garnock-Jones","year":"2012","unstructured":"Garnock-Jones KP. Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions. Paediatr Drugs. 2012;14(4):263\u20139. https:\/\/doi.org\/10.2165\/11208120-000000000-00000.","journal-title":"Paediatr Drugs"},{"issue":"4","key":"1173_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.clinthera.2012.02.026","volume":"34","author":"LS Eiland","year":"2012","unstructured":"Eiland LS. Glycopyrrolate for chronic drooling in children. Clin Ther. 2012;34(4):735\u201342. https:\/\/doi.org\/10.1016\/j.clinthera.2012.02.026.","journal-title":"Clin Ther"},{"key":"1173_CR12","doi-asserted-by":"publisher","unstructured":"Glycopyrronium for severe drooling in children. Drug Ther Bull. 2017;55(8):93\u20136. https:\/\/doi.org\/10.1136\/dtb.2017.8.0517.","DOI":"10.1136\/dtb.2017.8.0517"},{"issue":"5","key":"1173_CR13","first-page":"386","volume":"7","author":"VD Gupta","year":"2003","unstructured":"Gupta VD. Stability of oral liquid dosage forms of glycopyrrolate prepared with the use of powder. Int J Pharm Compd. 2003;7(5):386\u20138.","journal-title":"Int J Pharm Compd"},{"key":"1173_CR14","volume-title":"The Harriet Lane Handbook: A Manual for Pediatric House Officers","author":"J Flerlage","year":"2015","unstructured":"Flerlage J, Engorn B. The Harriet Lane Handbook: A Manual for Pediatric House Officers; 2015."},{"issue":"2","key":"1173_CR15","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1111\/j.1469-8749.2009.03519.x","volume":"52","author":"SM Reid","year":"2010","unstructured":"Reid SM, Johnson HM, Reddihough DS. The drooling impact scale: a measure of the impact of drooling in children with developmental disabilities. Dev Med Child Neurol. 2010;52(2):e23\u20138. https:\/\/doi.org\/10.1111\/j.1469-8749.2009.03519.x.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"1173_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF02412423","volume":"3","author":"N Thomas-Stonell","year":"1988","unstructured":"Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia. 1988;3(2):73\u20138. https:\/\/doi.org\/10.1007\/BF02412423.","journal-title":"Dysphagia."},{"key":"1173_CR17","unstructured":"https:\/\/www.drugs.com\/price-guide\/cuvposa (Accessed 03 Mar 2021)."},{"issue":"Suppl 2","key":"1173_CR18","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1038\/ejcn.2013.224","volume":"67","author":"JC Arvedson","year":"2013","unstructured":"Arvedson JC. Feeding children with cerebral palsy and swallowing difficulties. Eur J Clin Nutr. 2013;67(Suppl 2):S9\u2013S12. https:\/\/doi.org\/10.1038\/ejcn.2013.224.","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"1173_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3109\/00016487309139776","volume":"75","author":"C Ekedahl","year":"1973","unstructured":"Ekedahl C, Hall\u00e9n O. Quantitative measurement of drooling. Acta Otolaryngol. 1973;75(5):464\u20139. https:\/\/doi.org\/10.3109\/00016487309139776.","journal-title":"Acta Otolaryngol"},{"issue":"9","key":"1173_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1017\/s0012162203001117","volume":"45","author":"JF Tahmassebi","year":"2003","unstructured":"Tahmassebi JF, Curzon ME. Prevalence of drooling in children with cerebral palsy attending special schools. Dev Med Child Neurol. 2003;45(9):613\u20137. https:\/\/doi.org\/10.1017\/s0012162203001117.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"1173_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1017\/S0012162206000235","volume":"48","author":"JJ Van der Burg","year":"2006","unstructured":"Van der Burg JJ, Jongerius PH, Van Hulst K, et al. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care. Dev Med Child Neurol. 2006;48(2):103\u20137. https:\/\/doi.org\/10.1017\/S0012162206000235.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"1173_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1440-1754.1997.tb00991.x","volume":"33","author":"LM Stern","year":"1997","unstructured":"Stern LM. Preliminary study of glycopyrrolate in the management of drooling. J Paediatr Child Health. 1997;33(1):52\u20134. https:\/\/doi.org\/10.1111\/j.1440-1754.1997.tb00991.x.","journal-title":"J Paediatr Child Health"},{"issue":"9","key":"1173_CR23","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1001\/archpedi.1996.02170340046009","volume":"150","author":"PA Blasco","year":"1996","unstructured":"Blasco PA, Stansbury JC. Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med. 1996;150(9):932\u20135. https:\/\/doi.org\/10.1001\/archpedi.1996.02170340046009.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1173_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/TCRM.S26893","volume":"8","author":"RS Zeller","year":"2012","unstructured":"Zeller RS, Lee HM, Cavanaugh PF, Davidson J. Randomized phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions. Ther Clin Risk Manag. 2012;8:15\u201323. https:\/\/doi.org\/10.2147\/TCRM.S26893.","journal-title":"Ther Clin Risk Manag"},{"issue":"12","key":"1173_CR25","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1001\/archpedi.154.12.1214","volume":"154","author":"RJ Mier","year":"2000","unstructured":"Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M. Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med. 2000;154(12):1214\u20138. https:\/\/doi.org\/10.1001\/archpedi.154.12.1214.","journal-title":"Arch Pediatr Adolesc Med."},{"key":"1173_CR26","volume-title":"Summary of product characteristics, EU. Proveca Limited","author":"Sialanar 320 micrograms \/ml oral solution","year":"2017","unstructured":"Sialanar 320 micrograms \/ml oral solution. Summary of product characteristics, EU. Proveca Limited, 2017."}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-01173-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-021-01173-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-01173-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T20:04:47Z","timestamp":1636229087000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-021-01173-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,6]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1173"],"URL":"https:\/\/doi.org\/10.1186\/s13052-021-01173-7","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,6]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Nothing to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}